News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors
Clinical Forum Insights

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Clinical Forum Insights
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Antimicrobial Stewardship|
Bench to Bedside With SIDP|
C. difficile |
Clinical Corner|
Fungal Infections|
Hepatitis|
RSV: A New Era in Prevention
Advertisement

Sean S. M. Bullis, MD

Advertisement

Sean Bullis, MD, is an infectious diseases physician at The University of Vermont Medical Center and assistant professor of medicine at Larner College of Medicine at The University of Vermont in Burlington.

Articles by Sean S. M. Bullis, MD

Reduced-Dose Trimethoprim-Sulfamethoxazole Effective in Treating Mild to Moderate Pneumocystis jirovecii Pneumonia

ByKyle Crooker, MD,Eleanor Stedman, MD,Sean S. M. Bullis, MD,Andrew J. Hale, MD
September 20th 2022

Here is a review of using this therapy in this patient population.

Is There a Better Choice Than TMP-SMX to Treat Stenotrophomonas maltophilia Infections?

ByKyle Crooker, MD,Sean S. M. Bullis, MD,Andrew J. Hale, MD
December 16th 2021

Mono or Combo? Exploring the Role of Combination Antimicrobial Therapies for Invasive Carbapenem-Resistant Gram-Negative Infections

BySean S. M. Bullis, MD,Andrew J. Hale, MD
August 17th 2021
Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Contagion Live

    1

    US Completely Revamps Childhood Vaccine Schedule to Resemble Small European Country

    2

    A Dose of Clarity: Low- vs High-Dose Trimethoprim-Sulfamethoxazole for Stenotrophomonas maltophilia Pneumonia

    3

    The Great Debate: To Extend or Not Extend?

    4

    Training Healthcare Professionals to Treat High-Consequence Infectious Disease

    5

    Multicomponent Nudges Increase Influenza Immunization

    • About Us
    • Advertise
    • Editorial
    • Contact Us
    • Do Not Sell My Information
    • Privacy
    • Terms & Conditions
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us